Your browser does not support iframes.
TheStreet listed BioSante Pharmaceuticals Inc. (Nasdaq: BPAX) as one of six overvalued biotech stocks saying that it does not have any viable products in its pipeline sending the stock price tumbling 15 cents to $0.90.